Alan H. Bryce, MD @AlanBryce9 @MayoClinic #ASCO21 #Pros
Alan H. Bryce, MD, Medical Director of the Genomic Oncology Clinic at Mayo Clinic Arizona speaks about the ASCO 2021 Abstract – A phase 1b study of novel i
Related Articles
Overview of SYNC-T Technology from Syncromune in Prostate Cancer Treatment – Charles Link, MD
Dive into the SYNC-T technology by Syncromune® Inc. and its groundbreaking approach to hormone-refractory prostate cancer. Learn how it stimulates an immune response within the…
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD
Introduction to Emerging Therapies in ALL Management … Dr. Elias Jabbour shared recent developments in the treatment of acute lymphoblastic leukemia (ALL) during a recent…
Scott Kopetz, MD – KRYSTAL-1: Adagrasib-Cetuximab for KRASG12C CRC
Dr. Scott Kopetz discussed the KRYSTAL-1 study at AACR, presenting promising results of combining adagrasib and cetuximab to target KRASG12C mutated colorectal cancer, reporting a…
Ajay Goel, PhD – Exosome Biopsy Detects Pancreatic Cancer
Dr. Ajay Goel presented a novel blood-based liquid biopsy for early detection of pancreatic cancer, utilizing a combination of microRNAs and exosomes to achieve a…
Ajay Goel, PhD – Exosome Biopsy Detects Pancreatic Cancer
Dr. Ajay Goel presented a novel blood-based liquid biopsy for early detection of pancreatic cancer, utilizing a combination of microRNAs and exosomes to achieve a…
Revolutionizing Pancreatic Cancer Detection: The Groundbreaking Role of Liquid Biopsies – Ajay Goel, PhD [AACR 2024]
Uncover a revolutionary approach to pancreatic cancer detection. Delve into the study’s methodology and learn how microRNAs are used in liquid biopsies for unparalleled accuracy.
Targeting SCD1 in KRAS Mutant Non-Small Cell Lung Cancer: A Novel Therapeutic Strategy
Uncover the impact of SCD1 in NSCLC with concurrent KRAS, STK11, and KEAP1 mutations. Learn about the potential of SCD1 as a novel therapeutic target…
Lenvosiltamab: A Groundbreaking Advance in Multiple Myeloma Treatment
Learn about the remarkable response rate and complete response rate of Lenvosiltamab in multiple myeloma patients. Explore this potential paradigm shift in treatment.
Lurbinectedin: Enhancing Immunotherapy Efficacy in Small Cell Lung Cancer
Find out how combining traditional chemotherapies with Lurbinectedin can improve outcomes in small cell lung cancer. Discover the therapeutic potential of this innovative treatment.
Efficacy and Safety of Inotuzumab Ozogamicin – MOASC 2024
Mojtaba Akhtari, MD, FACP-Professor of Medicine-Loma Linda University explains the Efficacy and Safety of Inotuzumab Ozogamicin – from the MOASC 2024 Advances in Oncology meeting…